J D Termine
Overview
Explore the profile of J D Termine including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
121
Citations
3293
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taranta A, Brama M, Teti A, De Luca V, Scandurra R, Spera G, et al.
Bone
. 2002 Feb;
30(2):368-76.
PMID: 11856644
Raloxifene is a selective estrogen receptor modulator (SERM) that prevents bone loss. Although it is largely used for the treatment of osteoporosis, the mechanisms by which this compound modulates the...
2.
Bell N, Termine J
J S C Med Assoc
. 2001 Apr;
97(3):99-101.
PMID: 11285886
Osteoporosis is an important disease because of its prevalence and because it is associated with significant morbidity and mortality. As a consequence, development of new means of treating the disease...
3.
Termine J, Wong M
Maturitas
. 1999 Jan;
30(3):241-5.
PMID: 9881323
Objective: To briefly summarize the therapeutic choices for osteoporosis prevention which are currently available to post-menopausal women. Methods: Results of randomized clinical trials and epidemiological studies in postmenopausal women, and...
4.
Grese T, Sluka J, Bryant H, Cullinan G, Glasebrook A, Jones C, et al.
Proc Natl Acad Sci U S A
. 1998 Feb;
94(25):14105-10.
PMID: 9391160
Interaction of the estrogen receptor/ligand complex with a DNA estrogen response element is known to regulate gene transcription. In turn, specific conformations of the receptor-ligand complex have been postulated to...
5.
Yang N, Bryant H, Hardikar S, Sato M, Galvin R, Glasebrook A, et al.
Endocrinology
. 1996 May;
137(5):2075-84.
PMID: 8612550
Estrogen or raloxifene (LY156758) prevent estrogen deficiency-induced bone loss in animals and humans. We demonstrated in the rat that a 22% reduction in bone mineral density generated by ovariectomy was...
6.
Geerkens C, Vetter U, Just W, Fedarko N, Fisher L, Young M, et al.
Hum Genet
. 1995 Jul;
96(1):44-52.
PMID: 7607653
We report the mRNA and protein expression levels of human biglycan (BGN) in patients with different numbers of sex chromosomes. BGN maps to the distal long arm of the X...
7.
Fuchs-Young R, Glasebrook A, Short L, Draper M, Rippy M, Cole H, et al.
Ann N Y Acad Sci
. 1995 Jun;
761:355-60.
PMID: 7625735
No abstract available.
8.
Kerr J, Fisher L, Termine J, Wang M, MCBRIDE O, Young M
Genomics
. 1993 Aug;
17(2):408-15.
PMID: 8406493
We have isolated and partially sequenced the human bone sialoprotein gene (IBSP). IBSP has been sublocalized by in situ hybridization to chromosome 4q28-q31 and is composed of six small exons...
9.
Mintz K, Grzesik W, Midura R, Robey P, Termine J, Fisher L
J Bone Miner Res
. 1993 Aug;
8(8):985-95.
PMID: 8213261
Bone sialoprotein (BSP), a small (approximately 80,000 M(r)) integrin binding, RGD-containing bone matrix glycoprotein, has been purified in milligram quantities from the serum-free medium of the rat osteosarcoma cell line...
10.
Bianco P, Riminucci M, Silvestrini G, Bonucci E, Termine J, Fisher L, et al.
J Histochem Cytochem
. 1993 Feb;
41(2):193-203.
PMID: 8419459
Bone sialoprotein (BSP), a bone matrix-enriched glycoprotein containing the Arg-Gly-Asp (RGD) motif and endowed with cell binding properties, was localized in osteoblasts and early bone matrix of developing rat bone...